[Form 4] EASTMAN CHEMICAL CO Insider Trading Activity

Rhea-AI Filing Summary

Eastman Chemical executive Brad A. Lich reported an equity award of company stock. On February 11, 2026, the EVP & CCO acquired 18,861 shares of Eastman Chemical common stock at $0 per share as a grant based on performance for the three-year 2023–2025 period.

After this award, Lich beneficially owned 102,348 common shares directly, plus 2,594 shares indirectly through a 401(k) plan and 1,251 shares indirectly through an ESOP, reflecting his combined direct and plan-based holdings in Eastman Chemical.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider LICH BRAD A

Role EVP & CCO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	18,861	$0.00	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 102,348 shares (Direct); Common Stock — 2,594 shares (Indirect, By 401(k) Plan)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LICH BRAD A

(Last) (First) (Middle)

200 S. WILCOX DRIVE

(Street)

KINGSPORT TN 37660

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EASTMAN CHEMICAL CO [ EMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & CCO

3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/11/2026		A		18,861(1)	A	$0	102,348	D
Common Stock								2,594	I	By 401(k) Plan
Common Stock								1,251	I	By ESOP

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Determination of the number of performance shares earned for the three-year (2023- 2025) performance period.

Remarks:

	/s/ Mark D. Austin, by Power of Attorney for Brad A. Lich	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did EMN executive Brad A. Lich report?

Brad A. Lich reported receiving an equity award of Eastman Chemical common stock. On February 11, 2026, he acquired 18,861 shares at $0 per share as a non-cash grant tied to a three-year performance period from 2023 to 2025.

How many EMN shares did Brad A. Lich acquire in this Form 4 filing?

He acquired 18,861 shares of Eastman Chemical common stock. The shares were reported with a transaction code A, indicating a grant, award, or other acquisition, and were priced at $0 per share as part of a performance-based equity program for 2023–2025.

What is Brad A. Lich’s total direct ownership in Eastman Chemical after the grant?

After the grant, Brad A. Lich directly beneficially owned 102,348 shares of Eastman Chemical common stock. This figure reflects his direct holdings only and does not include additional indirect shares held through the company’s 401(k) plan or ESOP.

How are performance shares described in Brad A. Lich’s EMN Form 4 filing?

The filing explains that the reported shares reflect the determination of performance shares earned. Specifically, it notes the determination of the number of performance shares earned for the three-year performance period spanning 2023 to 2025, which resulted in the 18,861-share award.

What indirect EMN share holdings does Brad A. Lich report?

He reports indirect ownership of Eastman Chemical shares through benefit plans. The Form 4 lists 2,594 common shares held indirectly via a 401(k) plan and 1,251 common shares held indirectly through an employee stock ownership plan (ESOP), in addition to his direct holdings.

What role does Brad A. Lich hold at Eastman Chemical (EMN)?

Brad A. Lich serves as Executive Vice President and Chief Commercial Officer at Eastman Chemical. His role is noted in the filing under relationship to issuer, where he is identified as an officer with the title EVP & CCO, rather than as a director or 10% owner.